J&J’s DePuy Ortho faces $247m ruling in Pinnacle bellwether trial
NOVEMBER 17, 2017

A Dallas federal jury this week ruled that Johnson & Johnson (NYSE:JNJ) and its
DePuy Orthopaedics must pay $247 million to six patients claiming to be injured by its
Pinnacle metal-on-metal hip implants, according to a Reuters report.

The verdict is the fourth test trial in Dallas federal court over the
metal-on-metal Pinnacle hips, with over 9,000 cases pending.



Surgeon sues J&J’s DePuy in royalties dispute
OCTOBER 31, 2017

A surgeon who helped Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes Spine develop instruments
and implants for spine procedures wants a Massachusetts federal court to overturn an
arbitrator’s ruling that the company doesn’t owe royalties on the products, according to a
lawsuit filed last week in the Bay State.

Dr. Carl Lauryssen and his company, Jordan Consulting, helped develop the Mountaineer OCT spinal system
and thethe C1 drill guide for occipito-cervico-thoracic spinal fusion procedures.
The parties inked the development deal in 2003, but by November 2014 the arrangement had soured,
leading Lauryssen and Jordan to file for arbitration.
They alleged that DePuy breached the contract by underpaying royalties owed on the
Mountaineer system and failing to pay royalties for the C1 drill guide, according to an Oct.
27 complaint filed with the U.S. District Court for Massachusetts.

DePuy’s counterclaim alleged that the royalties arrangement ended in March 2010 and sought to
recoup royalties paid to Jordan and Lauryssen. Last month the arbitrator denied all of
Jordan and Lauryssen’s claims and agreed that the royalty deal expired in March 2010,
but denied DePuy’s bid to recoup any royalties, according to the complaint.